Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies
Dyskinetic and spastic movement disorders
Epilepsy
Huntington’s disease
Intractable seizures
Neurodegenerative diseases
Neuropathies
Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions
Parkinson’s disease
Post-traumatic stress disorder
Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain